www.cell.com
Open in
urlscan Pro
172.66.0.112
Public Scan
URL:
https://www.cell.com/trends/biotechnology/fulltext/S0167-7799(21)00056-1?dgcid=raven_jbs_aip_email
Submission: On December 10 via api from US — Scanned from US
Submission: On December 10 via api from US — Scanned from US
Form analysis
3 forms found in the DOMPOST /action/doLogin?redirectUri=https%3A%2F%2Fwww.cell.com%2Ftrends%2Fbiotechnology%2Ffulltext%2FS0167-7799%2821%2900056-1%3Fdgcid%3Draven_jbs_aip_email
<form action="/action/doLogin?redirectUri=https%3A%2F%2Fwww.cell.com%2Ftrends%2Fbiotechnology%2Ffulltext%2FS0167-7799%2821%2900056-1%3Fdgcid%3Draven_jbs_aip_email" method="post"><input type="hidden" name="redirectUri"
value="https://www.cell.com/trends/biotechnology/fulltext/S0167-7799(21)00056-1?dgcid=raven_jbs_aip_email"><input type="hidden" name="referer" value="/trends/biotechnology/fulltext/S0167-7799(21)00056-1?dgcid=raven_jbs_aip_email"><input
type="hidden" name="ecommRedirect"><input type="hidden" name="code" value="cell-site"><input type="hidden" name="UX3LoginWidget" value="true"><input type="hidden" name="isPopup" value="true">
<div class="input-group login-input--wrapper">
<div class="label"><label for="login">Email/Username</label></div><input id="login" type="text" name="login" value="" size="15" class="login">
<div role="alert" class="error-hint js--hidden">
<div class="error-hint__text">
<div class="error-text">Your email address is a required field.</div>
<div class="email-example">E.g., j.smith@mail.com</div>
</div>
</div>
</div>
<div class="input-group login-input--wrapper">
<div class="label"><label for="password">Password</label></div><input id="password" type="password" name="password" value="" autocomplete="off" class="password"><a href="#" class="login__field__action js-show-password">Show</a>
<div role="alert" class="error-hint js--hidden"><span class="error-hint__text">Your password is a required field.</span></div>
<div class="actions"><a href="https://www.cell.com/action/requestResetPassword" class="link show-request-reset-password">Forgot password?</a></div>
</div>
<div class="remember"><input type="checkbox" name="savePassword" id="a1f1ba25-79af-4194-aaa9-66206104a800-remember" value="1" checked="checked"><label for="a1f1ba25-79af-4194-aaa9-66206104a800-remember">Remember me</label></div>
<div class="submit"><input type="submit" name="submit" value="Log in" class="button submit primary"></div>
</form>
POST /action/requestResetPassword
<form action="/action/requestResetPassword" method="post" class="request-reset-password-form"><input type="hidden" name="platform"><input type="hidden" name="requestResetPassword" value="true"><input type="hidden" name="codeSite" value="cell-site">
<div class="input-group">
<div class="label"><label for="reset-password-email">Email*</label></div><input id="reset-password-email" type="text" name="email" value="" size="15" class="email">
</div>
<div class="submit" disabled="disabled"><input type="submit" name="submit" value="Submit" disabled="disabled" class="button primary submit"></div>
</form>
Name: quickSearchBar — GET https://www.cell.com/action/doSearch?journalCode=tibtec
<form action="https://www.cell.com/action/doSearch?journalCode=tibtec" name="quickSearchBar" method="get" title="Quick Search"><input id="type" type="hidden" value="quicksearch" name="type">
<div class="quick-search__toggle"><input id="searchText" type="text" name="text1" placeholder="Search for..." enterkeyhint="search" autocomplete="off" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3"
data-history-items-conf="3" data-group-titles-conf="3" data-publication-items-conf="3" aria-label="Enter a search term" class="searchText searchText-autocomplete ui-autocomplete-input"><button type="submit" title="Search"
aria-label="Submit the search form" class="btn quick-search__button icon-search"><span>Go
search</span></button><a href="https://www.cell.com/search/advanced?SeriesKey=tibtec&ISSN=0167-7799&journalCode=tibtec" title="Advanced search" class="quick-search__advanced-link">Advanced search</a>
<ul id="ui-id-1" tabindex="0" class="ui-menu ui-widget ui-widget-content ui-autocomplete ui-front" unselectable="on" style="display: none;"></ul>
</div>
<div class="quick-search__box">
<div class="quick-search__box-inner">
<div class="quick-search__box-wrapper"><select name="field1" aria-label="Select a search area">
<option value="AllField">All content</option>
<option value="Title">Article title</option>
<option value="Contrib">Authors</option>
<option value="Keyword">Keywords</option>
<option value="Abstract">Abstract</option>
<option value="AbstractTitleKeywordFilterField">Article title, abstract, keywords</option>
</select><input type="hidden" name="journalCode" value="tibtec">
<div class="quick-search__scope-options"><span>Search within:</span><label title="This journal" class="radio--primary"><input type="radio" name="SeriesKey" id="searchScopeSeries-a1f05748-166f-41e0-b01a-ca8ac1cc95d4" title="This journal"
value="tibtec" checked="checked" aria-label="Search within current journal"><span>This journal</span></label><label title="Full site" class="radio--primary"><input type="radio" name="SeriesKey"
id="searchScopeFullSite-a1f05748-166f-41e0-b01a-ca8ac1cc95d4" value="" title="Full site" aria-label="Search within full site"><span>Full site</span></label></div>
<a href="https://www.cell.com/search/advanced?SeriesKey=tibtec&ISSN=0167-7799&journalCode=tibtec" title="Advanced search" class="quick-search__advanced-link">Advanced search</a>
</div><a href="javascript:void(0)" aria-label="Close search options" title="Close search options" class="quick-search__box-close"><i aria-hidden="true" class="icon-tools_close"></i></a>
</div>
</div>
<div class="quick-search__alert hidden">
<p>Please enter a term before submitting your search.</p><a href="#" class="quick-search__alert--close"> Ok</a>
</div>
</form>
Text Content
Skip to Main Content Skip to Main Menu LOGIN TO YOUR ACCOUNT Email/Username Your email address is a required field. E.g., j.smith@mail.com Password Show Your password is a required field. Forgot password? Remember me Don’t have an account? Create a Free Account If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password Email* If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password Cancel ADVERTISEMENT SCROLL TO CONTINUE WITH CONTENT Open GPT Console Open Oracle Keywords Refresh Values Property Value Status Version Ad File Disable Ads Flag Environment Moat Init Moat Ready Contextual Ready Contextual URL Contextual Initial Segments Contextual Used Segments AdUnit SubAdUnit Custom Targeting Ad Events Invalid Ad Sizes Science that inspires A Cell Press journal * Submit * Log in * Register * Log in * Submit * Log in * Subscribe * Claim Access provided by Main menu * This journal * ABOUT * About this journal * About Trends Reviews journals * READ * Online now * Current issue * Archive * Publication alerts * Sneak Peek - preprints * * Journals * LIFE & MEDICAL SCIENCES * Cell * Cancer Cell * Cell Chemical Biology * Cell Genomics * Cell Host & Microbe * Cell Metabolism * Cell Reports * Cell Reports Medicine * Cell Stem Cell * Cell Systems * Current Biology * Developmental Cell * Immunity * Med * Molecular Cell * Neuron * Structure * American Journal of Human Genetics (partner) * Biophysical Journal (partner) * Biophysical Reports (partner) * Human Genetics and Genomics Advances (partner) * Molecular Plant (partner) * Molecular Therapy (partner) * Molecular Therapy Methods & Clinical Development (partner) * Molecular Therapy Nucleic Acids (partner) * Molecular Therapy Oncology (partner) * Plant Communications (partner) * Stem Cell Reports (partner) * Trends in Biochemical Sciences * Trends in Cancer * Trends in Cell Biology * Trends in Ecology & Evolution * Trends in Endocrinology & Metabolism * Trends in Genetics * Trends in Immunology * Trends in Microbiology * Trends in Molecular Medicine * Trends in Neurosciences * Trends in Parasitology * Trends in Pharmacological Sciences * Trends in Plant Science * PHYSICAL SCIENCES & ENGINEERING * Cell Biomaterials * Cell Reports Physical Science * Chem * Chem Catalysis * Device * Joule * Matter * Newton * Trends in Chemistry * MULTIDISCIPLINARY * Cell Reports Methods * Cell Reports Sustainability * Heliyon * iScience * One Earth * Patterns * STAR Protocols * Nexus (partner) * The Innovation (partner) * Trends in Biotechnology * Trends in Cognitive Sciences * Publish * AUTHORS * Submit article External Link * Propose new article * Author resources * Open access * Multi-Journal Submission * REVIEWERS * Information for reviewers * News & events * * Newsroom * Cell Symposia * Webinars * LabLinks * Consortia Hub * About Cell Press * CELL PRESS * About Cell Press * Contact us * Help & support External Link * Open access at Cell Press * Inclusion and diversity * 50th anniversary * HUBS * Biotechnology and bioengineering * Chemistry * Clinical and translational * COVID-19 * Fundamental biology * Sustainability * CAREERS * Cell Press careers External Link * Scientific job board External Link Go searchAdvanced search All contentArticle titleAuthorsKeywordsAbstractArticle title, abstract, keywords Search within:This journalFull site Advanced search Please enter a term before submitting your search. Ok Science & SocietyVolume 39, Issue 10p965-969October 2021Open access Download Full Issue Download started Ok BIOTECHNOLOGY AND BIOSAFETY POLICY AT OECD: FUTURE TRENDS Peter W.E. Kearns Peter W.E. Kearns Affiliations Former Principal Administrator (Biosafety), Organisation for Economic Co-operation and Development (OECD), Paris, France Search for articles by this author 1 ∙ Gijs A. Kleter Gijs A. Kleter 0000-0001-7030-1149 Correspondence Correspondence: gijs.kleter@wur.nl Affiliations Wageningen Food Safety Research (part of Wageningen University and Research), Wageningen, The Netherlands Search for articles by this author 2 gijs.kleter@wur.nl ∙ Hans E.N. Bergmans Hans E.N. Bergmans Affiliations Retired Official, Genetically Modified Organism (GMO) Office, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands Search for articles by this author 3 ∙ Harry A. Kuiper Harry A. Kuiper Affiliations Former GMO Panel Chair, European Food Safety Authority (EFSA), Parma, Italy Search for articles by this author 4 Affiliations & NotesArticle Info 1Former Principal Administrator (Biosafety), Organisation for Economic Co-operation and Development (OECD), Paris, France 2Wageningen Food Safety Research (part of Wageningen University and Research), Wageningen, The Netherlands 3Retired Official, Genetically Modified Organism (GMO) Office, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands 4Former GMO Panel Chair, European Food Safety Authority (EFSA), Parma, Italy Publication History: Published online March 19, 2021 DOI: 10.1016/j.tibtech.2021.03.001Also available on ScienceDirect Copyright: © 2021 The Authors. Published by Elsevier Ltd. User License: Creative Commons Attribution (CC BY 4.0) | Elsevier's open access license policy * Download PDFDownload PDF * Outline Outline * Abstract * Keywords * OECD and Its Legal Instruments * Suggestions for an Update to the Recommendation * Concluding Remarks * Acknowledgments * References * Article metrics * Related Articles * Share SHARE Share on * Email * X * Facebook * LinkedIn * Sina Weibo * Mendeley Add to my reading list * More More * Download PDFDownload PDF * Cite * Share SHARE Share on * Email * X * Facebook * LinkedIn * Sina Weibo * Mendeley Add to my reading list * Set Alert * Get Rights * Reprints Download Full Issue Download started Ok Previous articleNext article Show Outline Hide Outline * Abstract * Keywords * OECD and Its Legal Instruments * Suggestions for an Update to the Recommendation * Concluding Remarks * Acknowledgments * References * Article metrics * Related Articles ABSTRACT The OECD Council Recommendation on Recombinant DNA Safety Considerations is a legal instrument which has been in force since 1986. It outlines the safety assessment practices that countries should have in place for agricultural and environmental biotechnology. This article suggests possible updates to make it suitable for the modern era. KEYWORDS 1. recombinant DNA 2. food and feed safety 3. environmental safety 4. risk assessment 5. international harmonisation 6. OECD OECD AND ITS LEGAL INSTRUMENTS The Organisation for Economic Co-operation and Development (OECD) is an intergovernmental organisation with 37 member countries. In 1986, the OECD Council adopted a Recommendation entitled Recombinant DNA Safety Considerations: Safety Considerations for Industrial, Agricultural and Environmental Applications of Organisms Derived by Recombinant DNA Techniques [1 1. OECD Recommendation of the Council Concerning Safety Considerations for Applications of Recombinant DNA Organisms in Industry, Agriculture and the Environment (OECD/LEGAL/0225) Organisation for Economic Co-operation and Development, 1986 Google Scholar ]. This OECD legal instrument was intended to promote international understanding of safety issues raised by recombinant DNA (rDNA) techniques so as to take steps towards an international consensus on the protection of health and the environment as well as a reduction of non-tariff barriers to trade. It also marked the start of OECD's engagement with modern biotechnology, which continues today with a track record of seminal events and publications that have facilitated the international harmonisation of risk assessment principles (Box 1). More information on the OECD Convention and OECD legal instruments is available on the OECD website (www.oecd.org/legal/oecd-convention.htm). Box 1 OECD and Modern Biotechnology Since 1986 The OECD has published many documents since 1986 that include principles and/or guidance related to the risk/safety assessment of genetically modified organisms (GMOs) as well as of foods and animal feed derived from them (Figure I). Today, these principles and guidance documents could be important additions to the Recommendation (a summary of relevant OECD principles and guidance is given in Table I). The Recommendation was a good example of foresight when it was adopted in 1986, when most applications were restricted to containment facilities, although some of the first open-air field trials of GMOs were underway. It addresses issues relevant to human health, the environment, and agriculture that might be considered in a risk/safety assessment. Figure I Chronology of Seminal OECD Events and Publications on the Safety of Modern Biotechnology (1986–Present). Show full captionFigure viewer Abbreviations: WG-HROB, OECD Working Group on Harmonisation of Regulatory Oversight in Biotechnology; WG-SNFF, OECD Working Group on the Safety of Novel Foods and Feeds. Principle or guidanceSourceGMO development follows the principle of a stepwise approach, with risk/safety assessment being performed at each stage, from the laboratory to the growth chamber and greenhouse, to limited field testing, and finally to large-scale field testing.OECD, 1986 (Blue Book) [2 2. OECD Recombinant DNA Safety Considerations Organisation for Economic Co-operation and Development, 1986 Google Scholar ] OECD, 1986 (Council Recommendation) [1 1. OECD Recommendation of the Council Concerning Safety Considerations for Applications of Recombinant DNA Organisms in Industry, Agriculture and the Environment (OECD/LEGAL/0225) Organisation for Economic Co-operation and Development, 1986 Google Scholar ]Principle of case-by-case assessment. This principle implies that the risk/safety assessment of each case is performed individually using assessment criteria relevant to the particular case.OECD, 1986 (Blue Book) [2 2. OECD Recombinant DNA Safety Considerations Organisation for Economic Co-operation and Development, 1986 Google Scholar ]. OECD, 1986 (Council Recommendation) [1 1. OECD Recommendation of the Council Concerning Safety Considerations for Applications of Recombinant DNA Organisms in Industry, Agriculture and the Environment (OECD/LEGAL/0225) Organisation for Economic Co-operation and Development, 1986 Google Scholar ]Principle of risk/safety assessment and risk management. This process includes hazard identification and, if a hazard is identified, risk assessment. The process is based on the characteristics of the organism, the trait introduced, and the environment into which the organism is introduced, as well as the intended application.OECD, 1993 [6 6. OECD Safety Considerations for Biotechnology: Scale-up of Crop Plants Organisation for Economic Co-operation and Development, 1993 Google Scholar ,7 7. OECD Safety Evaluation of Foods Derived by Modern Biotechnology: Concepts & Principles Organisation for Economic Co-operation and Development, 1993 Google Scholar ]. Published under the auspices of the former OECD Group of National Experts on Safety in BiotechnologyThe principle of familiarity is used to address the environmental safety of GMOs. It is based on the understanding that most GMOs are developed from organisms such as crop plants whose biological characteristics are well understood. It allows risk assessors to use previous knowledge and experience with the introduction of GMOs into the environment, and this can indicate management measures.OECD, 1993 [6 6. OECD Safety Considerations for Biotechnology: Scale-up of Crop Plants Organisation for Economic Co-operation and Development, 1993 Google Scholar ,7 7. OECD Safety Evaluation of Foods Derived by Modern Biotechnology: Concepts & Principles Organisation for Economic Co-operation and Development, 1993 Google Scholar ]. Published under the auspices of the former OECD Group of National Experts on Safety in BiotechnologyThe OECD regularly publishes environmental safety Consensus Documents. These are in line with the principle of familiarity in that they contain information that member countries have agreed is relevant to the risk/safety assessment of GM plants and other GMOs. The subject of each document is a crop plant or another organism where GM varieties have been commercialised or are expected in the future.OECD, 2017 [8 8. OECD Introduction to the biosafety consensus documents Safety Assessment of Transgenic Organisms in the Environment (Vol. 7, OECD Consensus Documents) Organisation for Economic Co-operation and Development, 2017; 15-26 Crossref Google Scholar ].The principle of 'substantial equivalence', otherwise known as the comparative approach, is used in the food and feed safety assessment of products derived from GMOs. It involves the comparison of a new food or feed derived from a GMO with a similar product having a history of safe use, such that the safety evaluation can subsequently focus on any differences identified.OECD, 1993 [7 7. OECD Safety Evaluation of Foods Derived by Modern Biotechnology: Concepts & Principles Organisation for Economic Co-operation and Development, 1993 Google Scholar ]. Codex Alimentarius, 2009 [9 9. Codex Alimentarius Foods Derived from Modern Biotechnology Codex Alimentarius Commission, Joint FAO/WHO Food Standards Program, 2009 Google Scholar ].The OECD regularly publishes food/feed safety Consensus Documents which support the comparative approach. Each document has a crop plant as its subject, and includes data on key compositional parameters (nutrients, anti-nutrients, toxins, allergens) for the analysis of new variants of food- or feed-producing organisms including GM crops and several fungal species.OECD, 2019 [10 10. OECD Introduction to OECD work on novel food and feed safety Safety Assessment of Foods and Feeds Derived from Transgenic Crops (Vol. 3): Common Bean, Rice, Cowpea and Apple Compositional Considerations Organisation for Economic Co-operation and Development, 2019; 19-26 Crossref Google Scholar ]. Table I Summary of Relevant OECD Principles and Guidance (Consensus Documents) * Open table in a new tab This article argues that the Recommendation remains important and should be more widely known. First, it remains in force today and, although it is a recommendation, OECD practice accords recommendations 'great moral force as representing the political will of Adherents. There is an expectation that Adherents will do their utmost to fully implement a Recommendation'. It is unclear whether OECD members or the wider biotechnology community are aware of the Recommendation and its content. Second, candidate countries aspiring to OECD membership need to show that they are compliant with OECD legal instruments. Thirteen new members have joined the Organisation since the Recommendation was adopted. The OECD continues to expand its relationship with other non-members, many of which participate in its activities. In line with current OECD practice, the Recommendation is open to non-members. On December 2nd, 2020, Brazil became the first non-OECD country to adhere to the Recommendation. Many elements of the Recommendation are relevant today despite subsequent developments in genomic technologies as well as risk/safety assessment initiatives. An accompanying text that underpins the Recommendation, entitled Recombinant DNA Safety Considerations, coined the 'Blue Book' [2 2. OECD Recombinant DNA Safety Considerations Organisation for Economic Co-operation and Development, 1986 Google Scholar ], is an important reference to the thinking behind the Recommendation. SUGGESTIONS FOR AN UPDATE TO THE RECOMMENDATION This article has several suggestions for an update to the Recommendation, bearing in mind that a revision can only be undertaken by OECD through its committee structure. However, these suggestions are made in the belief that this Recommendation is an important instrument that should be more widely known and should be updated to accommodate developments since 1986. The Recommendation refers to 'recombinant DNA techniques' and rDNA organisms. Since 1986, however, a range of genomic techniques have been developed for modifying genomes that do not necessarily depend on rDNA. 'Genome editing', for instance, leads to some products that could also be produced using traditional techniques. In 2018, OECD held an international Conference on Genome Editing focusing on agricultural applications. It considered applications of genome editing in agriculture, including plant and animal breeding, and their implications for risk and safety considerations as well as regulatory aspects [3 3. Friedrichs, S. ... Meeting report of the OECD conference on 'Genome Editing: Applications in Agriculture – Implications for Health, Environment and Regulation' Transgenic Res. 2019; 28:419-463 Crossref Scopus (43) PubMed Google Scholar ]. From the panel discussions during this event, one of the findings that emerged was that there is a need for mutual understanding among nations about their respective regulatory approaches towards genome editing, possibly being even conducive to policy agreement. The need for such exchange among governments may be further compounded by the fact that genome editing is not solely the domain of major, globally operating biotechnology companies, and also engages small entrepreneurs and academics, as evident from the Argentinean experience [3 3. Friedrichs, S. ... Meeting report of the OECD conference on 'Genome Editing: Applications in Agriculture – Implications for Health, Environment and Regulation' Transgenic Res. 2019; 28:419-463 Crossref Scopus (43) PubMed Google Scholar ]. The scope of the Recommendation could be revised to encompass these new techniques should OECD Member States indeed have a shared need for harmonisation and extension of the current focus on rDNA. This article suggests that the Recommendation should be renamed 'Safety Considerations for Products of Modern Biotechnology: Applications in the Environment, Agriculture, and Food/Feed Production'. Section I of the Recommendation focuses on sharing experiences with rDNA organisms so as to harmonise approaches to rDNA techniques, emphasising that regulatory oversight should not unduly hamper technological developments. Exchange of information has always been a recurrent theme of OECD activities. It would be good to review the texts about not hampering technological developments in the light of the regulatory practice of today. It would also be advisable to attach an Annex to the Recommendation that provides a continuously updated list of existing Consensus Documents and other OECD documents that support risk/safety assessment. Section II could point out that the principle of good industrial large-scale practice, a topic which was last addressed at OECD in 1992 [4 4. OECD Safety Considerations for Biotechnology 1992 Organisation for Economic Co-operation and Development, 1992 7-16 Google Scholar ], remains valid for the handling of industrial microbial strains derived by modern biotechnology from safe parental strains. Section III, on agricultural and environmental applications, recommends that risk/safety assessment should take into account the familiarity that has been gained with 'the environmental and human health effects of living organisms'. The recommendations describe approaches to risk assessment that have become commonplace since the publication of the Recommendation, such as prior risk assessment, stepwise development, and the encouragement of 'research to improve the prediction, evaluation, and monitoring of the outcome of applications of rDNA organisms'. The footnote: '... this is not intended to imply that every case will require review by a national or other authority since various classes of proposals may be excluded' should be retained because probably not all member countries will wish to include all applications in their regulatory systems. The recitals, the introduction to the Recommendation, consider the future use of rDNA organisms. Many of the expectations in the recitals have come about. However, the landscape of 'rDNA' has changed, with many new possibilities. There is ongoing discussion about whether new products have the same novelty that led to the regulatory oversight that was deemed necessary for rDNA organisms. The recitals would also lend themselves to providing context and a future outlook. The approaches outlined by the Recommendation may be extended to other genomic techniques that do not entail the use of rDNA. A regular review and updating of the Recommendation would help to engender innovative safety assessment methodologies (e.g., analytical 'omic' approaches) that may be necessary to address the challenges that future synthetic biology products (e.g., xenobiotics, extensive engineering) may pose to the application of familiarity and the comparative safety assessment approach (Figure 1) [5 5. EFSA Scientific Committee ... Evaluation of existing guidelines for their adequacy for the microbial characterisation and environmental risk assessment of microorganisms obtained through synthetic biology EFSA J. 2020; 18:6263 Crossref Scopus (21) Google Scholar ]. Figure viewer Figure 1 The Comparative Approach as Applied to Food/Feed and Environmental Safety Assessments of Genetically Modified (GM) Crops. CONCLUDING REMARKS The Recommendation should take into account the accomplishments since 1986, and how the intentions of the Recommendation have largely come true, stating the importance of the principles of familiarity and the comparative approach as well as the case-by-case nature of the pre-market safety assessment of products of modern biotechnology. The revised Recommendation (an overview of detailed suggestions for amendments is given in Table 1) could look forward to the likely and preferred future developments within the purview of modern biotechnology, reflecting present-day discussions similarly to the original Recommendation. Section1986 RecommendationSuggested amendmentsI-aShare, as freely as possible, information on principles or guidelines for national regulations, on developments in risk analysis and on practical experience in risk management with a view to facilitating harmonization of approaches to recombinant DNA techniques.Expand scope by including non-recombinant DNA techniques. Also include non-agricultural applications. Mention OECD BioTrackb as a platform to exchange information. Expand the use of unique identifiers to microorganisms and animals.I-bExamine their existing oversight and review mechanisms to ensure that adequate review and control of the implementation of recombinant DNA techniques and applications can be achieved while avoiding any undue burdens that may hamper technological developments in this field.(same as for I-a above)I-cRecognise, when aiming at international harmonization, that any approach to implementing guidelines should not impede future developments in recombinant DNA techniques.Refer to internationally harmonised guidelines for food safety assessment (Codex Alimentarius Commission).I-dExamine at both national and international levels further developments such as testing methods, equipment design, and knowledge of microbial taxonomy to facilitate data exchange and minimise trade barriers between countries. Due account should be taken of ongoing work on standards within international organisations.Expand the scope (beyond microorganisms) to plants and animals.I-eMake special efforts to improve public understanding of the various aspects of recombinant DNA techniques.Include recent developments such as new breeding techniques.I-fWatch the development of recombinant DNA techniques for applications in industry, agriculture and the environment, while recognising that for certain industrial applications, and for environmental and agricultural applications of recombinant DNA organisms, some countries may wish to have a notification scheme.Replace 'recombinant DNA' by 'recently emerging genome-editing methods'.I-gEnsure that assessment and review procedures protect intellectual property and confidentiality interests in applications of recombinant DNA, recognising the need for innovation while still ensuring that all necessary information is made available to assess safety.Add that maximum transparency should be pursued, for example by making data accessible to public scrutiny. RECOMMENDS, with specific reference to agricultural and environmental applications, that Member countries: III-aUse the existing considerable data on the environmental and human health effects of living organisms to guide risk assessments.Refer to familiarity with particular modifications and/or traits. Acknowledge lack of familiarity with, for example, gene drives and synthetic organisms.III-bEnsure that recombinant DNA organisms are evaluated for potential risk, prior to applications in agriculture and the environment by means of an independent review of potential risks on a case-by-case basis.Require that safety assessments follow the principle of the comparative approach/substantial equivalence. Allow the assessment to be expedited based on familiarity.III-cConduct the development of recombinant DNA organisms for agricultural or environmental applications in a stepwise fashion, moving, where appropriate, from the laboratory to the growth chamber and greenhouse, to limited field testing and finally, to large-scale field testing.Maintain this recommendation for a stepwise approach.III-dEncourage further research to improve the prediction, evaluation, and monitoring of the outcome of applications of recombinant DNA organisms.Refer to the various Consensus Documents that will inform the risk assessment (to be appended). Table 1 OECD Council Recommendations Parts I and IIIa, and Suggested Amendments a Sections I and III contain recommendations to member countries on risk management in general (I) and specifically for environmental and agricultural purposes (III) [1 1. OECD Recommendation of the Council Concerning Safety Considerations for Applications of Recombinant DNA Organisms in Industry, Agriculture and the Environment (OECD/LEGAL/0225) Organisation for Economic Co-operation and Development, 1986 Google Scholar ]. b www.oecd.org/science/biotrack/ * Open table in a new tab ACKNOWLEDGMENTS ACKNOWLEDGEMENTS Financial support from the Dutch Ministry of Agriculture, Nature, and Food Quality (project WOT-02-004-052) for G.K.'s contribution is gratefully acknowledged. DECLARATION OF INTERESTS The authors declare no conflicts of interest. The views presented here are solely those of the authors and do not necessarily represent those of the OECD, the EFSA, or any other institution with which the authors are or have been associated. REFERENCES 1. OECD Recommendation of the Council Concerning Safety Considerations for Applications of Recombinant DNA Organisms in Industry, Agriculture and the Environment (OECD/LEGAL/0225) Organisation for Economic Co-operation and Development, 1986 Google Scholar 2. OECD Recombinant DNA Safety Considerations Organisation for Economic Co-operation and Development, 1986 Google Scholar 3. Friedrichs, S. ... Meeting report of the OECD conference on 'Genome Editing: Applications in Agriculture – Implications for Health, Environment and Regulation' Transgenic Res. 2019; 28:419-463 Crossref Scopus (43) PubMed Google Scholar 4. OECD Safety Considerations for Biotechnology 1992 Organisation for Economic Co-operation and Development, 1992 7-16 Google Scholar 5. EFSA Scientific Committee ... Evaluation of existing guidelines for their adequacy for the microbial characterisation and environmental risk assessment of microorganisms obtained through synthetic biology EFSA J. 2020; 18:6263 Crossref Scopus (21) Google Scholar 6. OECD Safety Considerations for Biotechnology: Scale-up of Crop Plants Organisation for Economic Co-operation and Development, 1993 Google Scholar 7. OECD Safety Evaluation of Foods Derived by Modern Biotechnology: Concepts & Principles Organisation for Economic Co-operation and Development, 1993 Google Scholar 8. OECD Introduction to the biosafety consensus documents Safety Assessment of Transgenic Organisms in the Environment (Vol. 7, OECD Consensus Documents) Organisation for Economic Co-operation and Development, 2017; 15-26 Crossref Google Scholar 9. Codex Alimentarius Foods Derived from Modern Biotechnology Codex Alimentarius Commission, Joint FAO/WHO Food Standards Program, 2009 Google Scholar 10. OECD Introduction to OECD work on novel food and feed safety Safety Assessment of Foods and Feeds Derived from Transgenic Crops (Vol. 3): Common Bean, Rice, Cowpea and Apple Compositional Considerations Organisation for Economic Co-operation and Development, 2019; 19-26 Crossref Google Scholar FIGURES (2)FIGURE VIEWER ARTICLE METRICS * * 10 Citations 23 Captures View details RELATED ARTICLES (40) * Impact of urbanization and human development on ecological footprints in OECD and non-OECD countries * Sarwar et al. HeliyonSeptember 18, 2024 * The influence of agricultural policy on carbon emissions in selected OECD countries * Fortune Ganda HeliyonSeptember 10, 2023 * A bibliometric analysis of maritime security policy: Research trends and future agenda * Kismartini et al. HeliyonApril 5, 2024 * Global biotechnology leapfrogging during the COVID-19 pandemic: a trend to stay? * Elena Borzova Trends in BiotechnologyJune 15, 2024 * Introducing original research at Trends in Biotechnology * Matthew J. Pavlovich Trends in BiotechnologyOctober 17, 2024 * Awareness of GMOs in terms of the Iran biosafety act: A case study of Tehran city * Shooshtari et al. HeliyonFebruary 2, 2024 * Qualitative document analysis on Iranian contents and trends of population policies: Lessons learned and avenues for future * Izadi et al. HeliyonJune 21, 2023 * Economic growth effects of public health expenditure in OECD countries: An empirical study using the dynamic panel threshold model * Hu et al. HeliyonFebruary 7, 2024 * Biosafety and biosecurity: treading China’s synbio tightrope * Lou et al. Trends in BiotechnologyNovember 11, 2023 * Bioeconomy and net-zero carbon: lessons from Trends in Biotechnology, volume 1, issue 1 * Jim Philp Trends in BiotechnologyOctober 19, 2022 * Assessing the initial impact of the Russian invasion on Ukrainian agriculture: Challenges, policy responses, and future prospects * Nehrey et al. HeliyonOctober 26, 2024 * The current status and future trends of BET research in oncology * Yu et al. HeliyonAugust 24, 2024 * Innovation trends in industrial biotechnology * Nielsen et al. Trends in BiotechnologyApril 19, 2022 * Are economic policy uncertainty and carbon futures price interacting? Evidence from the European Union * Li et al. HeliyonOctober 18, 2023 * A bibliometric analysis of biopesticides in corn pest management: Current trends and future prospects * Krismawati et al. HeliyonNovember 6, 2024 * Money grows on green energy: Financing a sustainable power future * Yang et al. HeliyonMarch 22, 2024 * The role of nanomaterials in revolutionizing ischemic stroke treatment: Current trends and future prospects * Wang et al. iScienceNovember 13, 2024 * Reducing education inequalities through cloud-enabled live-cell biotechnology * Vera-Choqqueccota et al. Trends in BiotechnologyAugust 28, 2024 * Generation mix and GDP growth in OECD countries * Harnphattananusorn et al. HeliyonSeptember 5, 2022 * Psychological capital research in HEIs: Bibliometric analysis of current and future trends * Zhang et al. HeliyonFebruary 16, 2024 * Bioinformational trends in grape and wine biotechnology * Dixon et al. Trends in BiotechnologyJune 7, 2021 * Physiological and pathological roles of PGAM5: An update and Future trend * He et al. iScienceDecember 5, 2024 * The evolution of smart hotels: A bibliometric review of the past, present and future trends * Liu et al. HeliyonFebruary 16, 2024 * Biotechnology for Tomorrow’s World: Scenarios to Guide Directions for Future Innovation * Cornelissen et al. Trends in BiotechnologyOctober 21, 2020 * A topic modeling-based analysis for the outcomes of psychological contract breaches and violations in organizations: Current research trends and future agenda * Akar et al. HeliyonJuly 19, 2024 * The biotechnology revolution in textile dyeing * Alves et al. Trends in BiotechnologyMarch 6, 2024 * Future trends of additive manufacturing in medical applications: An overview * Amaya-Rivas et al. HeliyonFebruary 22, 2024 * Toward understanding and utilizing crop heterosis in the age of biotechnology * Liu et al. iScienceJanuary 31, 2024 * Sustainable agriculture in the digital era: Past, present, and future trends by bibliometric analysis * Xu et al. HeliyonJuly 16, 2024 * Application of microbial resources in biorefineries: Current trend and future prospects * Gaur et al. HeliyonMarch 27, 2024 * Spatio-temporal variability and trends of air pollutants in the Metropolitan Area of Curitiba * Krecl et al. HeliyonNovember 21, 2024 * Characterize and analysis of meteorological and hydrological drought trends under future climate change conditions in South Wollo, North Wollo, and Oromia Zones, in Ethiopia * Alemu et al. HeliyonApril 13, 2024 * Darkweb research: Past, present, and future trends and mapping to sustainable development goals * Raman et al. HeliyonNovember 15, 2023 * Hotspots and future trends of autophagy in Traditional Chinese Medicine: A Bibliometric analysis * Zhao et al. HeliyonSeptember 22, 2023 * Options for environmental regulation policy under China's carbon peaking target: Energy supply policy or carbon tax policy? * Wang et al. HeliyonSeptember 17, 2024 * Safety by design: Biosafety and biosecurity in the age of synthetic genomics * Hoffmann et al. iScienceFebruary 9, 2023 * Airborne particulate matter integral assessment in Magdalena department, Colombia: Patterns, health impact, and policy management * Vergara-Vásquez et al. HeliyonAugust 15, 2024 * Agricultural biotechnology for sustainable food security * Tyczewska et al. Trends in BiotechnologyJanuary 27, 2023 * Biotechnology for a sustainable future: biomass and beyond * Yuan et al. Trends in BiotechnologyOctober 21, 2022 * Research trends, developments, and future perspectives in brand attitude: A bibliometric analysis utilizing the Scopus database (1944–2021) * Hashem E et al. HeliyonDecember 30, 2022 Show more Open in viewer Biotechnology and Biosafety Policy at OECD: Future Trends * * Hide CaptionDownloadSee figure in Article Toggle Thumbstrip * Figure I * Figure 1 * Download .PPT Go to Go to Show all references Expand All Collapse Expand Table Authors Info & Affiliations * * * * * * * Life & medical sciences journals * Cell * Cancer Cell * Cell Chemical Biology * Cell Genomics * Cell Host & Microbe * Cell Metabolism * Cell Reports * Cell Reports Medicine * Cell Stem Cell * Cell Systems * Current Biology * Developmental Cell * Immunity * Med * Molecular Cell * Neuron * Structure * American Journal of Human Genetics (partner) * Biophysical Journal (partner) * Biophysical Reports (partner) * Human Genetics and Genomics Advances (partner) * Molecular Plant (partner) * Molecular Therapy (partner) * Molecular Therapy Methods & Clinical Development (partner) * Molecular Therapy Nucleic Acids (partner) * Molecular Therapy Oncology (partner) * Plant Communications (partner) * Stem Cell Reports (partner) * Trends in Biochemical Sciences * * Trends in Cancer * Trends in Cell Biology * Trends in Ecology & Evolution * Trends in Endocrinology & Metabolism * Trends in Genetics * Trends in Immunology * Trends in Microbiology * Trends in Molecular Medicine * Trends in Neurosciences * Trends in Parasitology * Trends in Pharmacological Sciences * Trends in Plant Science Physical sciences & engineering journals * Cell Biomaterials * Cell Reports Physical Science * Chem * Chem Catalysis * Device * Joule * Matter * Newton * Trends in Chemistry Multidisciplinary journals * Cell Reports Methods * Cell Reports Sustainability * Heliyon * iScience * One Earth * Patterns * STAR Protocols * Nexus (partner) * The Innovation (partner) * Trends in Biotechnology * Trends in Cognitive Sciences Authors * Submit article * Multi-Journal Submission * STAR Methods * Sneak Peek – Preprints * Reviewers * Information for reviewers * News & events * Newsroom * Cell Symposia * Consortia Hub * Webinars * LabLinks * Multimedia * Cell Press Podcast * Cell Press Videos * Coloring and Comics * Figure360 * Cell Picture Show * Research Arc About * About Cell Press * Open access * COVID Hub * Sustainability hub * Inclusion and diversity * Contact * Contact us * Help & Support * Careers * Cell Press Careers * Scientific job board Access * Subscribe * Claim * Read-It-Now * Recommend to Librarian * Publication Alerts Collections * Best of Cell Press * Cell Press Reviews * Cell Press Selections * Nucleus Collections * SnapShot Archive Information * For Advertisers * For Recruiters * For Librarians * Privacy Policy * Terms and Conditions * Accessibility -------------------------------------------------------------------------------- The content on this site is intended for healthcare professionals and researchers across all fields of science. -------------------------------------------------------------------------------- We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie settings | Your Privacy Choices for this site. All content on this site: Copyright © 2024 Elsevier Inc., its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply. * Privacy Policy * Terms & Conditions * Accessibility * Help & Support * Contact ✓ Thanks for sharing! AddToAny More… __("articleCrossmark.closePopup") We use cookies that are necessary to make our site work. We may also use additional cookies to analyze, improve, and personalize our content and your digital experience. For more information, see ourCookie Policy Cookie Settings Accept all cookies COOKIE PREFERENCE CENTER We use cookies which are necessary to make our site work. We may also use additional cookies to analyse, improve and personalise our content and your digital experience. For more information, see our Cookie Policy and the list of Google Ad-Tech Vendors. You may choose not to allow some types of cookies. However, blocking some types may impact your experience of our site and the services we are able to offer. See the different category headings below to find out more or change your settings. You may also be able to exercise your privacy choices as described in our Privacy Policy Allow all MANAGE CONSENT PREFERENCES STRICTLY NECESSARY COOKIES Always active These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information. Cookie Details List FUNCTIONAL COOKIES Functional Cookies These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly. Cookie Details List PERFORMANCE COOKIES Performance Cookies These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. Cookie Details List TARGETING COOKIES Targeting Cookies These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. If you do not allow these cookies, you will experience less targeted advertising. Cookie Details List Back Button COOKIE LIST Search Icon Filter Icon Clear checkbox label label Apply Cancel Consent Leg.Interest checkbox label label checkbox label label checkbox label label Confirm my choices